HutchMED (China) LIMITED Payments to Acquire Productive Assets
HutchMED (China) LIMITED (HMDCF) reported Payments to Acquire Productive Assets of $30.66 million for the 6-month period ending 2023-06-30, per its 6-K filed 2023-07-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2023-07-31
- HutchMED (China) LIMITED payments to acquire productive assets for the quarter ending 2019-12-31 was $3.47M, a 141.31% increase year-over-year.
- HutchMED (China) LIMITED payments to acquire productive assets for the quarter ending 2019-09-30 was $3.42M, a 1.50% decline year-over-year.
- HutchMED (China) LIMITED payments to acquire productive assets for the quarter ending 2019-06-30 was $4.67M, a 790.46% increase year-over-year.
- HutchMED (China) LIMITED payments to acquire productive assets for the quarter ending 2019-03-31 was $1.28M, a 19.23% increase year-over-year.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2023-06-30 | $30.66M 6-K · filed 2023-07-31 | |||
| 2022-12-31 | $48.97M 20-F · filed 2023-02-28 | |||
| 2022-06-30 | $9.35M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $31.00M 20-F · filed 2023-02-28 | |||
| 2021-06-30 | $11.35M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $25.23M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $4.42M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $3.47M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $6.89M derived: sum of 2 quarters · filed 2022-03-03 | $11.55M derived: sum of 3 quarters · filed 2022-03-03 | $12.83M 20-F · filed 2022-03-03 |
| 2019-09-30 | $3.42M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $8.08M derived: sum of 2 quarters · filed 2020-07-30 | $9.36M 6-K · filed 2020-01-21 | $10.80M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $4.67M derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $5.94M 6-K · filed 2020-07-30 | $7.38M derived: sum of 3 quarters · filed 2021-03-04 | $10.85M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $1.28M 6-K · filed 2019-06-06 | $2.71M derived: sum of 2 quarters · filed 2021-03-04 | $6.18M derived: sum of 3 quarters · filed 2021-03-04 | $6.71M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $1.44M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $4.91M derived: sum of 2 quarters · filed 2021-03-04 | $5.43M derived: sum of 3 quarters · filed 2021-03-04 | $6.50M 20-F · filed 2021-03-04 |
| 2018-09-30 | $3.47M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $3.99M derived: sum of 2 quarters · filed 2020-01-21 | $5.06M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $524.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $1.59M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $1.07M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $6.07M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $3.04M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $4.33M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $1.57M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $3.32M 20-F · filed 2018-03-12 | |||
| 2014-12-31 | $4.62M 20-F · filed 2017-03-13 |